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Molecular mechanisms underlying terminal differen-
tiation of B cells into plasma cells are major determi-
nants of adaptive immunity but remain only partially
understood. Here we present the transcriptional
and epigenomic landscapes of cell subsets arising
from activation of human naive B cells and differenti-
ation into plasmablasts. Cell proliferation of acti-
vated B cells was linked to a slight decrease in DNA
methylation levels, but followed by a committal
step in which an S phase-synchronized differentia-
tion switch was associated with an extensive DNA
demethylation and local acquisition of 5-hydroxyme-
thylcytosine at enhancers and genes related to
plasma cell identity. Downregulation of both TGF-
b1/SMAD3 signaling and p53 pathway supported
this final step, allowing the emergence of a CD23-
negative subpopulation in transition from B cells
to plasma cells. Remarkably, hydroxymethylation of
PRDM1, a gene essential for plasma cell fate, was
coupled to progression in S phase, revealing an intri-
cate connection among cell cycle, DNA (hydroxy)
methylation, and cell fate determination.INTRODUCTION
Production of antibody-secreting cells from B cells is crucial
for adaptive immunity and involves a number of mechanisms
controlling B cell differentiation into plasmablast. B cell fate
determination proceeds autonomously and stochastically (Duffy
et al., 2012; Tangye et al., 2003) from a balance between division
and death, both parameters remaining highly variable at the sin-
gle-cell level (Duffy et al., 2012).Cell ReControl of terminal B cell differentiation by transcription fac-
tors operates following specific timing and pace that remain
only partially understood. A large number of external and internal
signals and cues impact this process by influencing transcrip-
tional cascades (Allman and Cancro, 2011). BCL6 has an antag-
onistic role to the plasmablast fate-determining transcription
factor BLIMP1, encoded by PRDM1, in lineage determination.
These two factors mutually inhibit each other, BLIMP1 having a
broad role in promoting plasma cell (PC) differentiation through
the repression of B cell signature genes including c-Myc, CIITA,
SPIB, LMO2, and PAX5 (Cubedo et al., 2011; Martins and Cal-
ame, 2008). BLIMP1 acts as a sequence-specific recruitment
factor for chromatin-modifying enzymes and corepressors
(Martins and Calame, 2008), and, even though earliest stages
of plasmablast commitment do not seem to require BLIMP1 (Kal-
lies et al., 2004), high BLIMP1 expression levels matter for matu-
ration and maintenance of long-lived PCs (Kallies et al., 2007).
Both IRF4 and XBP-1 also are required for PC differentiation. If
the latter acts downstream of BLIMP1, it is still unclear how
IRF4 is positioned (Nutt et al., 2011). In human centrocytes,
IRF4 is expressed concomitantly with BLIMP1 (Cattoretti et al.,
2006), and in mouse, secreted IgM is detected in the absence
of functional BLIMP1, suggesting the existence of a preplasma-
blast state (Kallies et al., 2007; Kuo et al., 2007) that could be rep-
resented in human by B cells expressing low levels of PAX5 and
PRDM1 associated to high IRF4 levels (Jourdan et al., 2011).
Finally, the existence of critical thresholds for specific transcrip-
tion factors (Kallies et al., 2004; Ochiai et al., 2013) suggests
the establishment of multilayered repression loops between
these factors, a process driving B cell fate in an autonomous
and stochastic manner and most likely coordinated at an epige-
netic level.
Hematopoiesis involves reprogramming of epigenetic modifi-
cations associated with development (Cedar and Bergman,
2011). Cell cycle, and in particular DNA synthesis during S
phase, provides a window of opportunity for chromatin remodel-
ing of genes from an inactive to an active state duringports 13, 1059–1071, November 3, 2015 ª2015 The Authors 1059
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hematopoietic cell differentiation (Bird, 2002; Bird et al., 1998;
Pop et al., 2010). For instance, during CD4+ helper T cell differ-
entiation, intricate proliferation and differentiation signals lead to
erasure of epigenetic constraints, such as DNA methylation at
CpGs (Bird et al., 1998). DNA methylation may directly interfere
with the binding of transcription factors to their cognate DNA se-
quences or may enable recruitment of methyl-CpG-binding pro-
teins, which induce a repressed chromatin environment (Bird,
2002). Kriaucionis and Heintz (2009) showed the presence of
5-hydroxymethylcytosine (5hmC) in brain DNA and suggested
that this DNA state could represent an oxidative intermediate
in a pathway of active DNA demethylation with potentially impor-
tant biological roles. Accordingly, 5hmC was later found to be
enriched at active genes and enhancers, as well as at the start
sites of genes whose promoters bear dual H3K27me3 and
H3K4me3 marks (Melle´n et al., 2012; Pastor et al., 2011; Se´ran-
dour et al., 2012; Stroud et al., 2011). Simultaneously, the
production of 5hmC through hydroxylation of the methyl group
of 5-methylcytosine by TET1 protein was demonstrated in
mammalian cells (Tahiliani et al., 2009). The discovery that TET
proteins are involved in self-renewal of stem cells, cell differenti-
ation, and reprogramming opened new perspectives for the un-
derstanding of cell plasticity (Koh et al., 2011; Madzo et al., 2014;
Szulwach et al., 2011).
Here by activating human naive B cells (NBCs) in vitro (Le Gal-
lou et al., 2012),wecaptured heterogeneousBcell fates andearly
committed states otherwise too transient to be identified by
in vivo analyses. Cells undergoing exponential growth upon stim-
ulation were sorted and subsequently analyzed, allowing the
identification of multiple cell subsets based on lineage-specific
gene expression. Our results show an entanglement between
cell division anddifferentiation programsalongwith a cellularma-
chinery largely open toward apoptosis. The final step of commit-
ment, when a human B cell ended as a plasmablast, was
captured and found to be synchronized with the cell cycle and
associated with a dynamic demethylation process involving
5hmC apposition on plasmablast fate-determining genes.
RESULTS
Cell Proliferation Sustains Plasmablast Generation
Carboxyfluoroescein diacetate succinimidyl ester (CFSE)-
labeled human CD19+CD27 NBCs were differentiated in vitro
as described in Figure 1A (LeGallou et al., 2012).We have shown
previously that the first days of the culture are associated with aFigure 1. Relationship between Cell Proliferation and B Cell Fate
(A) CFSE-labeled NBCs were differentiated using a two-step cell culture process g
CFSE dilution and CD38 expression at D6.
(B) Proliferation and apoptosis of the three generated populations at D6 were det
(percentage of positive cells ± SD; n = 8). Intracellular IgG and membrane expres
experiment among five).
(C) Transcriptional profiling of eight genes was done using qRT-PCR on sorted P
cells at D4 (mean values ± SD; n = 5).
(D) P2 compartment was sorted out at D5, labeled for 30 min with BrdU, and
experiment among four).
(E) Cells were sorted at D4 in CFSEhigh and CFSElow cycling (Hoechst+, H+) or n
analysis was performed by qRT-PCR and results are expressed relative to gene ex
***p < 0.001).
Cell Retranscriptional burst and proliferation in response to the activa-
tion cocktail. At day 4 (D4), cells presented a downregulation
of BCL-6, BACH2, and PAX5 and started to upregulate
PRDM1, XBP1, and IRF4 compared to NBCs. These modifi-
cations were more pronounced in CFSElow compared to
CFSEhigh cells, which is consistent with a commitment to the
plasmablast fate linked to high proliferation.
We next focused on the process of terminal differentiation. At
D6, CD38 and CFSE detection allowed discrimination of three
cell populations, hereafter referred to as P1, P2, and P3 (Fig-
ure 1A). BrdU uptake, active caspase-3 and CD138 membrane
expression, as well as intracellular IgG staining showed that P1
cells corresponded to proliferative plasmablasts able to undergo
class switch recombination and to give rise to CD138+ PCs (Fig-
ure 1B). Both P2 and P3 corresponded to highly apoptotic post-
activated B cells containing a low fraction of cycling cells, in
which both cell death and low proliferation could be counterbal-
anced by CD40L/NF-kB pathway activation (data not shown),
suggesting that apoptosis observed in those cells mainly was
due to the removal of the activation cocktail rather than a vital
exhaustion that could be expected after a 6-day culture. Expres-
sion of eight selected genes (Figure 1C) confirmed that P1 corre-
sponded to plasmablasts characterized by elevated XBP1,
PRDM1, and IRF4 and decreased SPIB, BCL-6, PAX5,
BACH2, and IRF8 mRNA levels. Interestingly, compared to D4
and unlike P3, P2 cells upregulated PRDM1, IRF4, and XBP1,
whereas BCL-6 and PAX5 presented nonsignificant changes,
suggesting that P2 forms a heterogeneous compartment con-
taining cells committed to plasmablastic fate. The proportion
of cycling P2 cells was quite stable throughout experiments
(z20%, n = 8) and not affected when apoptosis was inhibited
(data not shown). We next sorted out the P2 compartment at
D5 and labeled it for 30’ with BrdU before putting cells back in
culture for 24 hr. At D6, emerging P1 cells were 90.4% ± 3.8%
(n = 3) positive for BrdU (Figure 1D), indicating that dividing P2
cells contain plasmablasts precursors. Conversely, sorted P3
cells were unable to generate P1 cells (data not shown).
To analyze gene expression profiles of cells engaged in cell di-
vision (i.e., >2N DNA content) compared to those in G0/G1, cells
were stained with Hoechst before sorting several cell subsets at
D4 and D6. As early as D4 among the five selected genes, a sig-
nificant downregulation of BACH2 was found in Hoechst-posi-
tive (S and G2/M phases) compared to Hoechst-negative (G1
phase) cells, reflecting an early commitment of the former
cells toward plasmablasts (Figure 1E). At D6, cycling P2 cellsiving rise to three different cell populations called P1, P2, and P3, according to
ermined, respectively, using BrdU incorporation and active caspase-3 staining
sion of CD138 also were evaluated at D6 by FACS analysis (one representative
1, P2, P3, and D4 cells. Results are expressed relative to gene expression in B
analyzed at D6 for CD38 expression and BrdU labeling (one representative
ot (Hoechst, H) and at D6 in P1, P2 cycling (H+), or not (H). Transcriptional
pression in a pool of tonsil B cells (mean values ±SD; n = 5; *p < 0.05, **p < 0.01,
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Figure 2. Cell Type-Specific Gene Expression in
P1, P2, and P3 Generated Populations
(A) The one-way repeated-measures ANOVA with an
FDR < 5% was used on the raw data, allowing us to
generate 9,599 probe sets corresponding to 5,632 single
genes. The principal component analysis revealed for
the first (PC1, with 48% of the variables) and second
(PC2, with 23.6%of the variables) components a specific
ordering among cell populations following a proliferation
and differentiation axis.
(B) Unsupervised hierarchical clustering allowed
defining P1-specific up- and downregulation signatures
including 1,794 genes and 2,534 genes, respectively.We
compared the log2 mean intensity of each signature for
all cell populations. The arrow indicates the specific
position for P2 cells.
(C) Top 5 molecular and cellular functions and top 5
upstream regulators was obtained using Ingenuity soft-
ware analysis. The asterisk relates to the prediction
abbreviations (A, activated; I, inactivated; NSp, not
specified; NE, not evaluated because excluded from the
dataset; NS, not significant).completed their commitment with the downregulation of LMO2,
BCL-6, and SPIB, leading to a gene expression pattern close
to P1 cells. These results indicate the need for further cell divi-
sions beyond D4 to complete plasmablastic differentiation. In
contrast, the upregulation of LMO2 and BCL6 expression in
the Hoechst-negative P2 subset indicated that these cells drifted
away from a PC destiny (Figure 1E).
Concomitant p53 Pathway Inhibition and G1/S
Transition Promotion in P1 Committed Cells
To determine the transcriptional program sustaining plasmablast
emergence, we performed microarray-based gene expression
profiling comparing five paired cell subsets, including CFSElow
and CFSEhigh cells obtained at D4 (hereafter referred as D4lo
and D4hi) and P1, P2, and P3 sorted at D6 (Figure S1A). Principal
component analysis allowed drawing a common proliferation
and differentiation axis along which P2 cells occupied an inter-
mediate position between the most and less polarized P1 and
P3 cells, respectively (Figure 2A). Unsupervised clustering
showed that P1 cells were hierarchically separated from the
others and were characterized by 1,794 P1-specific upregulated
genes and 2,534 P1-specific downregulated genes (Figure S1B).
By computing the mean log2 intensity for both gene lists on each
cell population, we confirmed the proliferation-based hierarchi-
cal cell classification with P2 being at a crossroad position, sug-
gesting that in our model these cells can either progress to P1 or
to cell death (Figure 2B).
We next established gene lists of factors differentially ex-
pressed between P1 and P2, P1 and D4lo, as well as D4lo and1062 Cell Reports 13, 1059–1071, November 3, 2015 ª2015 The AuthorsD4hi. By using Ingenuity software, we found
that the most prominent function that differed
in P1 versus P2 was cell death and survival,
and the top 5 upstream regulators predicted
inactivation of the p53 pathway in P1 with the
highest significance (Figure 2C). Although
dead cells were removed from this transcrip-tomic analysis, we could not exclude an impact of the presence
of potentially apoptotic P2 cells. However, the observations
made by comparing P2 and P1 cells were already apparent in
D4lo compared to D4hi, two populations that are not apoptotic
(data not shown). The p53 pathway analysis revealed that 32 of
79 genes (40%) related to this pathway had a differential expres-
sion in P1 compared to P2, of which 19 varied significantly (p <
0.05) (listed in Table S1). Although TP53 expression itself was
not significantly modified in P1 cells in microarray data, qRT-
PCR analysis showed a consistent downregulation (Figure S1C).
Inactivation of the p53 pathway was evidenced by upregulation
of MDM2 as well as BCL2L1 and BIRC5—two genes inhibited
by p53—while NOXA, a p53-activated gene, was downregu-
lated. As expected for PC precursors, BCL2 showed a striking
downregulation in P1 cells, counterbalanced by an upregulation
of BCL2L1. Overall, the P1 population was characterized by a
decreased susceptibility to cell death and an inactivation of the
p53 pathway, which should allow for a potent induction of G1/
S phase transition as well as progression in S phase (Yin et al.,
1992; Zhang et al., 2000). Pathway analysis identified a G1/S
transition promotion in P1 cells, characterized by a pronounced
downregulation of the TGF-b1/SMAD3 pathway associated with
an increased expression of CDC25A and a promotion of its
activity (Ray et al., 2005; Figure S2).
The Last Commitment Step toward Plasmablasts Is
Synchronized with the S Phase of the Cell Cycle
To identify P1 founder cells, we looked for differentially ex-
pressed cell membrane markers between P1 and P2. In this
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Figure 3. Cycling CD23-Negative P2 Cells Incorporate P1 Founder Cells
(A) FACS analysis of CD23 expression at D6 on P1, P2, and P3 cells. Histogram plots are representative of ten experiments.
(B) Percentage of cycling cells in ten different experiments was evaluated in CD23/P2 and CD23+/P2 subsets at D6 after Hoechst staining.
(C) Evaluation of apoptosis by active caspase-3 intracellular staining in association with CD23 cell surface staining of P2 cells cultured in the presence of the pan-
caspase inhibitor QVD-OPH or DMSO. Dot and histogram plots are representative of four experiments.
(D) CD23 and CD23+ P2 cells cultured in the presence of QVD-OPH were sorted at D5 according to CD23 expression, labeled for 30 min with BrdU, and
analyzed at D6 for CD38 expression and BrdU labeling (one representative experiment among four).
(E) Transcriptional analysis of P2 subsets compared to P1 population at D6. CD23+ (gray bars) and CD23 (black bars) P2 cells were divided into cycling (H+) and
non-cycling (H) subsets after a combined CD23/Hoechst staining and cell sorting. Results are expressed relative to gene expression in CD23+/H/P2 cells
(mean values ± SD; n = 5). Only statistics between CD23 subsets and P1 cells are represented (*p < 0.05; **p < 0.01).context, we evidenced an inhibition of the IL-4 pathway in P1,
secondary to STAT6 downregulation and associated with
decreased expression of IL4R, CD23, and CIITA targets (Fig-Cell Reure S3A). Consistent with this finding, expression of CD23 at
the cell surface was negative for P1, positive for P3, and bimodal
for P2 (Figure 3A). Flow cytometry analysis of cytokine-deprivedports 13, 1059–1071, November 3, 2015 ª2015 The Authors 1063
D6 cells stimulated with IL-4 for 10 min uncovered a striking cor-
relation between intracellular p-STAT6 and membrane CD23
expression, with P1 cells being totally negative for both proteins
(Figure S3B). At D6, the number of cycling CD23/P2 cells was
twice that of CD23+ cells (Figure 3B), and, as P1 cells, these cells
downregulated membrane IgD, CD83, and HLA-DR expression
(data not shown). Of note, more than 70% of these cells were
caspase-3a+, indicating that dying cells lose the CD23 marker
likely through a process different from STAT6 inhibition since
the proportion of CD23/P2 cells fell to 10%–20% in the pres-
ence of the pan-caspase inhibitor Q-VD-OPH added at D4 (Fig-
ure 3C). Since CD23 could be lost on apoptotic cells, cell sorting
of CD23 and CD23+ P2 cells was performed in the presence of
Q-VD-OPH in order to capture cells that have downregulated
CD23 expression in an apoptotic-independent manner. As ex-
pected, CD23 cells presented a higher propensity to give rise
to P1, indicating that the non-apoptotic CD23 subset of P2
hosts plasmablastic founder cells (Figure 3D). However,
although it does not affect differentiation, the use of Q-VD-
OPH is still an artificial way to get rid of apoptotic cells that are
losing CD23. In the absence of the pan-caspase inhibitor, cas-
pase-3+ cells were excluded from cell sorting using a permeable
detection system for active caspase-3, and, as previously
observed, CD23 cells presented a better capacity to differen-
tiate than the CD23+/P2 cells (Figure S4A). Finally, BrdU pulse-
chase experiments confirmed that plasmablasts emerged from
cycling CD23/P2 cells (Figure 3D).
We next sorted out subsets of Hoechst-positive (H+)
and -negative cells (H) at D6 from the CD38low/CD23/
CFSElow compartment (for gating strategy, see Figure S3C,
top), and we performed qRT-PCR analysis on genes selected
based on microarray data in order to determine the potential
commitment of these cells to plasmablast differentiation.We evi-
denced that P2 cells that progress toward P1 fate first downre-
gulate the pSTAT6/CD23 pathway and then, during a unique
cell division, end as P1 cells (Figure 3D). Indeed, for almost all
tested genes except CD38, a shift in the expression patterns be-
tween CD23 subsets and CD23+ counterparts was observed
(Figure 3E). This result was confirmed even when apoptotic cells
were excluded from the analysis (Figure S4B). Likewise, a signif-
icant downregulation of B cell identity genes BCL6, BACH2,
IRF8, SPIB, and PAX5 was observed in CD23/H+/P2 cells,
with a pattern almost identical to P1 (Figure 3E). This CD23/
H+/P2 subset gained this typical transcriptional profile in cells
in S phase, indicating that gene expression changes leading to
plasmablasts occurred during an S phase of the cell cycle
(Figure S3C).
Plasmablast Commitment Is Associated with a Wide
Loss of DNA Methylation
To gain insights into the epigenetic mechanisms modulating
gene expression changes observed in our in vitro model, we
profiled DNA methylation in different B cell subsets using the
Illumina 450K microarray technology. This analysis was done
on D0 (NBCs), D4hi, D4lo/H+, D4lo/H, P2/H, P2/H+, P3,
and P1 cell compartments obtained from three different subjects
plus tonsil-derived plasmablasts. In unsupervised principal
component analysis, NBCs and plasmablasts clustered sepa-1064 Cell Reports 13, 1059–1071, November 3, 2015 ª2015 The Autrately, and the different in-vitro-generated cells were located in
between according to a hierarchical ordering. This observation
is consistent with previous findings emphasizing the effect of
cell proliferation and shows D4lo/H+ and P2/H+ to cluster
together at an intermediate position before P1 and plasmablasts
purified from tonsils (Figure 4A). These two later showed a
marked loss of methylation by unsupervised clustering
compared to the other cell populations (Figure 4B). Dot-blot
analysis of global 5-methylcytosine (5mC) levels in genomic
DNA confirmed the decrease in methylation in P1 cells
compared to NBCs (Figure 4C).
We next identified CpGs whose methylation is modulated
during terminal B cell differentiation. As compared to NBCs,
the CpGs hypomethylated in P1 and purified plasmablasts
showed a major overlap (Figure 4D), suggesting that our
in vitro model recapitulates the DNA methylation changes that
take place in vivo. We then compared DNA methylation pat-
terns of the sequentially obtained cell subpopulations and
observed a clear DNA methylation loss between NBCs and
D4lo/H+ (4,292 CpGs), which continued in H+/P2 versus
D4lo/H+ (518 CpGs) and became particularly extensive in P1
versus H+/P2 (13,660 CpGs) (Figure 4E). Conversely, only
very few CpGs became hypermethylated during differentiation
(for instance 85 CpGs in P1 versus NBCs). To investigate the
functional significance of these epigenetic changes, hypome-
thylated CpGs were annotated using chromatin state-derived
genomic coordinates from immortalized mature B cells (Ernst
et al., 2011; Kulis et al., 2012), which showed a DNA methyl-
ation profile similar to PCs (Figure 4B). Interestingly, hypome-
thylated regions showed a specific enrichment in enhancer
elements (2.4- to 5-fold, yellow color) as compared to the dis-
tribution of the 450K array, in all three comparisons (Figure 4F).
This finding suggests that in vitro differentiation of NBCs into
plasmablasts associates with a gradual demethylation of en-
hancers. Furthermore, such demethylation of functional ele-
ments frequently targeted genes related to PC differentiation.
Indeed, among the 18 selected genes analyzed at the transcrip-
tional level in Figure 3E plus SDC1 (alias CD138), CIITA, and
CCND1, 13 genes showed a hypomethylation of the 28 CpGs
present on the array, when comparing P1 to NBCs (Figure 4G).
However, one CpG located within the P1-repressed SPIB gene
showed a similar behavior, suggesting that hypomethylation, as
assessed here, is not necessarily a hallmark of gene activation.
In addition, a limitation to these analyses is that the bisulfite
treatment used to treat DNA prior to hybridization to the 450K
arrays does not discriminate 5mC from 5hmC (Huang et al.,
2010), hence limiting the possibility to characterize in detail
the molecular mechanisms involved in DNA demethylation dur-
ing plasmablast commitment.
Molecular and Cellular Functions Involved in
Plasmablast Emergence Are Associated with Selective
5hmC Enrichment at PC Identity Genes
To determine if an active DNA demethylation mechanism
was involved, genome-wide mapping of 5hmC was undertaken,
using a selective chemical labeling (SCL) strategy (Song
et al., 2011). Global levels of 5hmC were first analyzed by dot
blot and data showed a dramatic decrease in 5hmC duringhors
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Figure 4. Modulation of the DNA Methylome during In Vitro and In Vivo Differentiation of NBCs into Plasmablasts
(A) Unsupervised principal component analysis of microarray DNAmethylation data shows a hierarchical distribution of the samples along an axis going from the
less differentiated cells (NBCs, green color at the left) to the most mature tonsil-derived plasmablasts (pink color at the right).
(B) Unsupervised hierarchical clustering of microarray data is shown (28,774 CpGs with SD > 0.1 among of all samples).
(C) The 5mC dot blot shows total genomic DNA from NBCs and D6 P2 and P1 subsets (one representative experiment among three).
(D) Density plot showing the gradual decrease in DNA methylation upon in vitro differentiation of NBCs into P1, which reach a DNA methylation pattern similar to
in-vivo-generated plasmablasts. Incrustation: Venn diagram shows the overlap of hypomethylated sites in P1 and plasmablasts as compared to NBCs.
(E) Schematic representation shows the number of hypomethylated CpGs taking place in key cell subpopulations between NBC and P1.
(F) Characterization of hypomethylated CpGs into chromatin states between is shown. Blue, depletion; yellow, enrichment.
(G) Multiple genes associated with PC differentiation show hypomethylation in P1 and plasmablasts as compared to NBCs (same color scheme and methylation
scale as in B).
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Figure 5. Genome-wide and Gene-Specific
Analysis of 5hmC-Enriched Regions from
NBCs and Plasmablasts
(A) Variations in intragenic 5hmC levels and histone
modifications correlate with gene regulation during
plasmablast differentiation. Integrated Genome
Browser views show 5hmC, H3K4me1, and H3K27ac
levels in genes activated (PRDM1 and XBP1) or
repressed (SPIB and IRF8) during differentiation for
NBCs and P1.
(B) Genes that are associated with 5hmC-enriched
regions have a significantly higher expression when
compared to genes devoid of 5hmCs in NBCs and P1
cells (p < 2.2e16, Wilcoxon rank-sum test).
(C) Metagene average profile of 5hmC enrichment
according to P1 gene expression levels. Quartiles of
genes were obtained based on transcriptomic data.
Blue line, least expressed genes; black line, highest
expressed genes.
(D) Relative mRNA expression (black bars; mean
values ± SD; n = 3) and 5-hmC density (gray bars;
reads densities in counts per million [cpm], back-
ground substracted, at gene loci ±100 kb) for selected
genes in P1 cells compared to NBCs are shown.
(E) Overlap between 5hmC-enriched regions and
H3K4me1- and H3K27ac-positive regions in NBCs
and P1 cells. Bars indicate the percentage of 5hmC-
positive regions that also are positive for either
H3K4me1 (dark brown) or H3K27ac (orange) or both
(gray).differentiation of NBCs into P1 cells (Figure S5A, left). In addition,
5hmC levels were even lower in tonsil-derived plasmablasts and
almost undetectable in human bone marrow-derived PCs from
healthy donors (Figure S5A, right). This global loss in DNA hy-
droxymethylation could reflect a passive demethylation process
due to a dilution of 5mC during multiple rounds of DNA synthesis
or an absence of 5hmC maintenance during cell differentiation.
Consistent with the latter hypothesis, TET expression levels
decreased dramatically throughout the cell differentiation pro-
cess (Figure S5B). However, 5hmC maps generated from blood
and lymph node (LN) NBCs as well as from plasmablasts (P1
cells and purified plasmablasts) indicated that, although the
number of identified hydroxymethylated unique regions
decreased between LN NBCs (24,405; p = 1e8) and P1 cells1066 Cell Reports 13, 1059–1071, November 3, 2015 ª2015 The Authors(12,542; p = 1e8), specific regions gained
5hmC during differentiation (Figures 5A and
S6A). Importantly, B cell identity genes lost
5hmC in P1, whereas PC identity genes
gained 5hmC in P1 together with chromatin
marks of active enhancers (H3K4me1 and
H3K27ac, Figure 5A). Accordingly, a posi-
tive correlation between gene expression
levels and DNA 5-hydroxymethylation was
observed (Figure 5B) and was particularly
prominent in gene bodies (Figure 5C).
This correlation also was true for selected
NBC- and plasmablast-expressed genes
(Figure 5D), suggesting that changes in
5hmC levels mirror those in gene expression,a behavior that might apply to most down- and upregulated
genes during plasmablast differentiation (Figure S6B).
At a global level, a dramatic redistribution of the 5hmC peaks
was observed in P1 cells compared to LN NBCs as suggested
by their poor overlap (12.4%, Figure S6C), although 5hmC was
mainly enriched in introns and intergenic regions for both cell
types (Figure S6D). A comparison of the genome-wide distribu-
tion of 5hmC with that of active enhancer marks (H3K4me1
and H3K27ac) indicated that, as already observed in other
cell systems (Se´randour et al., 2012; Shen et al., 2013; Stroud
et al., 2011), a large fraction of 5hmC-enriched regions might
be related to enhancers (Figure 5E). These observations also
are consistent with the fact that 25%–51% of hypomethylated
CpGs during the differentiation process were located in
Figure 6. SCL-qPCR Analysis of 5hmC Enrichment in Genomic Regions of PRDM1 and SPIB
(A–C) 5hmC enrichment at PRDM1 (A–C, left) and SPIB (A–C, right) in the indicated cell-sorted compartments (n = 3). Note that PRDM1- and SPIB-associated
hydroxymethylation could not be detected by SCL-qPCR in genomic DNA from bone marrow PCs.
(D) Pyrosequencing analysis of the methylation status of three CpGs included in the PRDM1 region analyzed by SCL-qPCR (n = 1–3 per CpG and cell
subpopulation).enhancers (Figure 4F), suggesting that these regulatory re-
gions undergo active DNA demethylation. Collectively, these
data indicate that changes in the transcriptome during NBC
differentiation toward plasmablasts are accompanied by a
dramatic reorganization of the pool of active enhancers,
which are characterized by an active turnover of cytosine
modifications.
The kinetics of cytosine hydroxymethylation events occurring
at SPIB and PRDM1 next were interrogated through SCL-qPCR
(Figure 6A), and data revealed that changes in 5hmC levels
correlated with the gene expression changes depicted in Figures
1E and 3E. Interestingly, PRDM1 5hmC levels started to rise only
once P2 cells had lost the CD23 marker and underwent division
(H+/P2 cells), indicating that targeting of PRDM1 by TET activity
is coupled with S/G2 phase progression (Figures 6B and 6C).
Bisulfite conversion and pyrosequencing revealed that the
DNAmethylation levels of three CpGs included in the PRDM1 re-
gion analyzed by SCL-qPCR did not show clear significant vari-
ations between cell states except for bone marrow-derived PCs,
which had a 30% reduction in DNA methylation (Figure 6D).
This observation indicates that methylation of these particular
CpGs was pre-established in NBCs and, hence, that PRDM1 hy-
droxymethylation in CD23/P2 cells may not require de novo
methylation at these sites. Furthermore, the reduction in DNA
methylation levels in PCs suggests that cytosine hydroxymethy-
lation in PRDM1 may represent an intermediate step of DNA
demethylation in plasmablasts and P1 cells.Cell ReDISCUSSION
Our study characterizes molecular events taking place when
a human activated B cell switches to a plasmablast, an anti-
body-secreting precursor of the long-lived PC. Our findings sup-
port a model that relies on twomajor processes: (1) a continuous
integration of extracellular signals inducing cell proliferation and
waves of DNA demethylation, notably at enhancers; and (2) a
committal step where the cell cycle clock is precisely synchro-
nized with and coordinates a plasmablastic differentiation
switch, reflected by the selective occurrence of 5hmC in regions
enriched in specific PC identity genes (Figure 7).
Consistent with a normal germinal center reaction, only highly
proliferative cells can differentiate into PCs in an in vitro model of
B cell differentiation (Tangye et al., 2003). B cell differentiation is
sustained by an extensive reconfiguration of gene expression
patterns and of the epigenetic landscape of the cell, including
a progressive loss of DNA methylation (Kulis et al., 2015; Lai
et al., 2013; Lee et al., 2012). In this study, a two-step differenti-
ation protocol could transform human blood NBCs into a cell
population (P1) that could not be distinguished from human
tonsil-derived plasmablasts. This process depended on the
emergence of plasmablast founder cells in the P2 population,
characterized by their exit from the apoptotic program and their
capacity to recycle in the absence of BCR cross-linking, TLR
activation, and CD40 stimulation. In the absence of IL-2 during
the first step of cell culture, generation of plasmablasts wasports 13, 1059–1071, November 3, 2015 ª2015 The Authors 1067
Figure 7. Schematic Representation of Human NBC Differentiation and Destiny
During the first 4 days (left), B cells proliferate and dilute the CFSE stain in response to the first stimulation cocktail (stim1) that induces IL-2, CD40, TLR, and BCR
signaling. BetweenD4 andD6 (right), cells under influence of the second stimulation cocktail (stim2, including only cytokines) can acquire two alternative states as
follows: lowly divided P3 cells and highly divided P2 cells. P2 cells upregulate PRDM1, downregulate SPIB, maintain cell divisions, and frequently undergo
apoptosis. In addition, these cells are characterized by a proliferation-dependent DNA demethylation drift. A small fraction of P2 cells can emerge as CD23-
negative/STAT-6-negative founder plasmablasts (red nucleus P2 cell) that undergo a committal step of B cell differentiation characterized by G1-S and S phase
promotion, p53 pathway inhibition, and specific apposition of 5hmC on PC identity genes. This epigenetic phenomenon is likely to sustain high expression of PC
fate-determining genes including PRDM1, allowing full maturation of PCs. PB, plasmablast.impeded without affecting the capacity of P2 cells to proliferate
(Le Gallou et al., 2012), suggesting that only cells that integrated
a proper number of external cues were able to undergo final dif-
ferentiation. Although commitment toward plasmablasts already
was distinguishable after 4 days in culture (as assessed by BCL6
and BACH2 expression), cells underwent cell death beyond D4
unless they were able to trigger a molecular switch turning off
the p53 pathway and IL4/STAT6 signaling. Subsequently, cells
lost the membrane marker CD23, reflecting their transition
from B cell identity to plasmablastic destiny. Our data suggest
that this committal step takes place during the S phase of the
cell cycle and requires S phase progression of cells undergoing
a TGF-b1/SMAD3-regulated G1/S transition.
Since this final differentiation process seemed to be cell cycle
dependent, we hypothesized that going through an S phase
progression could provide a window for chromatin remodeling
events required for transcriptional switches (Bird, 2002; Bird
et al., 1998; Pop et al., 2010). Consistent with data obtained on
sorted human mature B cells engaged in an immune response
(Lai et al., 2013), we uncovered a high correlation among cell pro-
liferation, levels of differentiation, and DNA demethylation. DNA
demethylation occurred progressively with cell culture time
and became particularly extensive at the final step of differentia-
tion. A global evaluation of 5hmC levels in genomic DNA from1068 Cell Reports 13, 1059–1071, November 3, 2015 ª2015 The Autvarious cell states showed a striking decrease during differenti-
ation, with in-vitro-generated or primary plasmablasts maintain-
ing very low 5hmC levels, whereas 5hmC was undetectable in
long-lived PCs. Although these 5hmC levels were not high
enough to be detected with ox-BS-450K arrays (data not
shown), the use of the highly sensitive SCL procedure allowed
us to evidence a selective gain in 5hmC during differentiation
at genes and enhancers related to PC identity.
High levels of BLIMP1 are required to get fully mature PCs
(Kallies et al., 2004), and the selective 5hmC enrichment of
PRDM1 during the last step of differentiation could participate
in the setup of a chromatin state, allowing high transcription of
this gene. Consistent with this hypothesis, we evidenced a gen-
eral correlation between gene expression and 5hmC presence in
gene bodies, suggesting that, despite the very low levels of
5hmC detected in P1 cells, 5hmC might be functionally relevant
in these cells and impact on the establishment of a plasmablast-
specific transcriptome. Here we have further explored this rela-
tionship by studying the kinetics of 5hmC apposition at
PRDM1 by SCL-qPCR in parallel to the analysis of the methyl-
ation status of three specific CpGs by pyrosequencing. Although
stable DNAmethylation was detected throughout the cell culture
period, 5hmC apposition was found to occur specifically in
CD23 and Hoechst+ cells of the P2 population. These laterhors
also presented the closest gene expression profile compared to
the one of plasmablasts, suggesting that targeting of PRDM1 by
TET activity is coupled with S phase progression and activation
of the gene. Although a link between DNA synthesis and cytosine
hydroxymethylation has not yet been evidenced, TET proteins
could be targeted to replication forks through association with
PCNA, as suggested from interaction assays in cancer cell lines
(Cartron et al., 2013).
Hence, the molecular control of PC generation involves a pre-
cise committal step during which activated B cells escaping cell
death turn on plasmablast fate-determining genes, most likely as
a result of an active and cell cycle-synchronized demethylation
process.
EXPERIMENTAL PROCEDURES
Primary B Cell Purification
Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were
obtained from the Etablissement Franc¸ais du Sang after Ficoll density centri-
fugation (Sigma-Aldrich). NBCs were purified by negative selection using
magnetic cell separation (Naive B Cell Isolation kit II, Miltenyi Biotech),
following the manufacturer’s instructions, using the AutoMACS deplete-sen-
sitive program. Purity of isolated CD19+/CD27 NBCs was routinely above
99%. Reactive lymph node-derived NBCs, as well as tonsil plasmablasts,
were isolated as previously described (Caron et al., 2009). CD38hi/CD138+
PCs were purified from bone marrow aspirates obtained from patients
undergoing cardiac surgery. Subjects were recruited under institutional re-
view board approval and informed consent according to the Declaration of
Helsinki.
Cell Culture, Immunophenotyping, and Cell Sorting
Cell culture conditions, antibodies, and flow cytometry procedures were as
previously described (Le Gallou et al., 2012). Briefly, purified human NBCs
were labeled with 1 mM CFSE (Invitrogen) for 10 min before subsequent cell
culture at 7.5 3 105 cells/ml in 24-well plates and stimulation with cocktail 1
described in Figure 1A for 4 days. Activated B cells were then washed and
further cultured with cocktail 2 (Figure 1A).
After surface staining, the Cytofix/Cytoperm kit (BD Biosciences) was used
for intracellular staining of active caspase-3 and IgG. Proliferation was
analyzed using an antigen-presenting cell (APC)-conjugated anti-BrdU kit
(BD Biosciences) according to the manufacturer’s instructions.
For qRT-PCR analyses, B cells were isolated at D4, D5, or D6 by fluores-
cence-activated cell sorting (FACS) with an ARIA cell sorter (BD Biosciences)
after DAPI (Sigma-Aldrich) staining to exclude dead cells. For cell sorting ac-
cording to DNA content, cells were incubated at 23 106/ml in culture medium
for 30 min at 37C in the presence of 5 mg/ml Hoechst 33342 (Sigma-Aldrich).
qRT-PCR Analysis
RNA was extracted using RNeasy microkit (QIAGEN) and reverse transcribed
into cDNA with Superscript II (Invitrogen). The qRT-PCRs were performed us-
ing the TaqMan Universal Master Mix and assays-on-demand from Applied
Biosystems. Gene expression levels were quantified using ABL1 as endoge-
nous control. The 2 exp(DDCt) method was used to determine the relative
expression of each gene. Data were compared using the Mann-Whitney test
(GraphPad Prism Software).
Gene Expression Profiling
RNA samples of five cell populations (D4lo, D4hi, P1, P2, and P3) were hybrid-
ized onto Affymetrix Human Genome U219 Array Plates according to Affyme-
trix standard protocols. The analysis of scanned images for each probe set of
the arraywas obtainedwithGeneChipOperating Software (GCOS, Affymetrix).
Raw CEL files were processed and normalized with the robust multichip
average (RMA) algorithm using R statistical software in conjunction with the
Affy library available through Bioconductor. One-way repeated-measuresCell ReANOVA was used (false discovery rate [FDR] < 5%) to determine the genes
that differed significantly between at least two of the five cell populations.
Subsequent analyses were performed on these differentially expressed
genes only.
Gene clusters were obtained from an unsupervised hierarchical clustering
method using Euclidean distance and average linkage for clustering samples
and Pearson’s dissimilarity and Ward’s method for clustering probe sets. By
averaging the gene expressions within these clusters, we defined supergenes
that were used to display a concise summary of the changes across time
points and across cell populations. Paired two-tailed t test was used to iden-
tify the differentially expressed genes between two distinct populations as
well as between each population versus all the other populations. In this
last case, gene expressions of all other populations were averaged in the
linear domain then log transformed for each subject prior to t test analysis.
Canonical pathways and biological functions were generated by Ingenuity
Pathways Analysis (Ingenuity Systems). These statistical analyses were
performed using Partek Genomic Suite (version 6.6). Microarray data, as
well methylation and hydroxymethylation data, are publicly available at
GEO: GSE72498.
DNA Methylation Analysis Using 450K Microarray
We used the EZ DNA Methylation Kit (Zymo Research) for bisulfite conversion
of 500 ng genomic DNA. Bisulfite-converted DNA was hybridized onto the
HumanMethylation 450K BeadChip kit (Illumina), which covers 99% of RefSeq
genes and 96% of CpG islands. The Infinium methylation assay was
carried out following the manufacturer’s instructions. Data from the 450K
HumanMethylation array were analyzed in R using the minfi package (version
1.6.0) available through Bioconductor. For more details, see the Supplemental
Experimental Procedures.
Bisulfite Pyrosequencing
The DNA methylation status of three CpGs of PRDM1 was quantified in sorted
cell subpopulations by bisulfite pyrosequencing using the PyroMark Q96 ID
sequencer (QIAGEN), as previously described (Tost and Gut, 2007). DNA
methylation levels were quantified with the PyroMark CpG software (QIAGEN).
For primers details, see the Supplemental Experimental Procedures.
Genome-wide Mapping of 5hmC and Data Analysis
Genomic DNA (7 mg) from NBCs and plasmablasts was fragmented to
200–500 bp by sonication (Bioruptor, Diagenode) before incubation with
b-glucosyltransferase and azide-glucose. Glucosylated 5hmCs were then
labeled with biotin before enrichment of the biotinylated DNA fragments
with streptavidin-coated magnetic beads. All steps used reagents from
the Hydroxymethyl Collector kit (Active Motif). After elution from the
beads, purified DNA was precipitated and processed for sequencing on a
Highseq2000 (Illumina). Library preparations and sequencing reactions
were run at the Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire
(IGBMC) genomic platform. Unique sequencing reads were mapped to the
reference genome (hg19) using bowtie (Langmead et al., 2009) allowing
one mismatch. For more details on analysis and PCR primers for SCL-
PCR, see the Supplemental Experimental Procedures. For correlation anal-
ysis of 5hmC enrichment and gene expression data, see the Supplemental
Experimental Procedures.
ChIP-Seq Procedure
Chromatin immunoprecipitation sequencing (ChIP-seq) was performed in P1
cells following standard protocols generated within the Blueprint Consortium.
Briefly, cells were fixed for 8 min in 1% formaldehyde at room temperature and
chromatin was sonicated for 15 min with the Bioruptor Sonication System
(Diagenode). Immunoprecipitation was carried out with antibodies fromDiage-
node against H3K4me1 (pAb-194-050, lot A1863-001P) and H3K27ac (pAb-
196-050, lot A1723-0041D), using approximately 500,000 cells per antibody.
ChIP-seq libraries were constructed using the Kapa Hyper Prep Kit (Kapa Bio-
systems). For each experiment, from 26 to 81 million reads were sequenced
with an Illumina HiSeq1500 sequencer. Detailed protocols can be obtained
from the Blueprint Consortium: http://www.blueprint-epigenome.eu/index.
cfm?p=7BF8A4B6-F4FE-861A-2AD57A08D63D0B58.ports 13, 1059–1071, November 3, 2015 ª2015 The Authors 1069
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